nach oben

Erschienen in:

2018 | OriginalPaper | Buchkapitel

12. Dendrimer-Based Nanoplatforms for SPECT Imaging Applications

verfasst von : Lingzhou Zhao, Xiangyang Shi, Jinhua Zhao

Erschienen in: Nanotechnology Characterization Tools for Biosensing and Medical Diagnosis

Verlag: Springer Berlin Heidelberg

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Dendrimers can be functionalized with multiple imaging and therapeutic moieties to establish dendrimer-based nanoplatforms for various applications. In this chapter we describe the recent progress in dendrimer-based nanomaterials for SPECT imaging applications with different purposes.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Photoacoustic Imaging Tools for Nanomedicine

Nächstes Kapitel In Vivo Near-Infrared Fluorescence Imaging Based on Polymer Dots

Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372(9):793–795CrossRef

Jameson JL, Longo DL (2015) Precision medicine – personalized, problematic, and promising. N Engl J Med 372(23):2229–2234CrossRef

Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452(7187):580–589CrossRef

Pysz MA, Gambhir SS, Willmann JK (2010) Molecular imaging: current status and emerging strategies. Clin Radiol 65(7):500–516CrossRef

Kircher MF, Hricak H, Larson SM (2012) Molecular imaging for personalized cancer care. Mol Oncol 6(2):182–195CrossRef

Naumova AV, Modo M, Moore A, Murry CE, Frank JA (2014) Clinical imaging in regenerative medicine. Nat Biotechnol 32(8):804–818CrossRef

Chan KW-Y, Wong W-T (2007) Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging. Coord Chem Rev 251(17–20):2428–2451CrossRef

Li J, Zheng L, Cai H, Sun W, Shen M, Zhang G, Shi X (2013) Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging. Biomaterials 34(33):8382–8392CrossRef

Jin R, Lin B, Li D, Ai H (2014) Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications. Curr Opin Pharmacol 18:18–27CrossRef

10.

Li L, Gao F, Jiang W, Wu X, Cai Y, Tang J, Gao X, Gao F (2016) Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imaging. Drug Deliv 23(5):1726–1733

11.

Mustafa R, Zhou B, Yang J, Zheng L, Zhang G, Shi X (2016) Dendrimer-functionalized laponite nanodisks loaded with gadolinium for T1-weighted MR imaging applications. RSC Adv 6(97):95112–95119CrossRef

12.

Suzuki H, Oshima H, Shiraki N, Ikeya C, Shibamoto Y (2004) Comparison of two contrast materials with different iodine concentrations in enhancing the density of the aorta, portal vein and liver at multi-detector row CT: a randomized study. Eur Radiol 14(11):2099–2104CrossRef

13.

Hainfeld JF, Slatkin DN, Focella TM, Smilowitz HM (2006) Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 79(939):248–253CrossRef

14.

Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J, Carey TE, Kopelman R (2008) Targeted gold nanoparticles enable molecular ct imaging of cancer. Nano Lett 8(12):4593–4596CrossRef

15.

Peng C, Zheng L, Chen Q, Shen M, Guo R, Wang H, Cao X, Zhang G, Shi X (2012) PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials 33(4):1107–1119CrossRef

16.

Zhang Y, Wen S, Zhao L, Li D, Liu C, Jiang W, Gao X, Gu W, Ma N, Zhao J, Shi X, Zhao Q (2016) Ultrastable polyethyleneimine-stabilized gold nanoparticles modified with polyethylene glycol for blood pool, lymph node and tumor CT imaging. Nanoscale 8(10):5567–5577CrossRef

17.

Ametamey SM, Honer M, Schubiger PA (2008) Molecular imaging with PET. Chem Rev 108(5):1501–1516CrossRef

18.

Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, Coleman RE, Wahl R, Paschold JC, Avril N, Einhorn LH, Suh WW, Samson D, Delbeke D, Gorman M, Shields AF (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49(3):480–508CrossRef

19.

Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B, Wisniewski T, de Leon MJ (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease. Eur J Nucl Med Mol Imaging 36(5):811–822CrossRef

20.

Brindle K (2008) New approaches for imaging tumour responses to treatment. Nat Rev Cancer 8(2):94–107CrossRef

21.

Shirani J, Dilsizian V (2011) Nuclear cardiac imaging in hypertrophic cardiomyopathy. J Nucl Cardiol 18(1):123–134CrossRef

22.

Wang G, Stender AS, Sun W, Fang N (2010) Optical imaging of non-fluorescent nanoparticle probes in live cells. Analyst 135(2):215–221CrossRef

23.

Hellebust A, Richards-Kortum R (2012) Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. Nanomedicine (Lond) 7(3):429–445CrossRef

24.

James ML, Gambhir SS (2012) A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 92(2):897–965CrossRef

25.

Cai H, Li K, Shen M, Wen S, Luo Y, Peng C, Zhang G, Shi X (2012) Facile assembly of Fe₃O₄@Au nanocomposite particles for dual mode magnetic resonance and computed tomography imaging applications. J Mater Chem 22(30):15110–15120CrossRef

26.

Herschman HR (2003) Molecular imaging: looking at problems, seeing solutions. Science 302(5645):605–608CrossRef

27.

Hoffman JM, Gambhir SS (2007) Molecular imaging: the vision and opportunity for radiology in the future. Radiology 244(1):39–47CrossRef

28.

Luo S, Zhang E, Su Y, Cheng T, Shi C (2011) A review of NIR dyes in cancer targeting and imaging. Biomaterials 32(29):7127–7138CrossRef

29.

Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41(8):1369–1379

30.

Keidar Z, Israel O, Krausz Y (2003) SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 33(3):205–218CrossRef

31.

Jennings LE, Long NJ (2009) ‘Two is better than one’-probes for dual-modality molecular imaging. Chem Commun (24):3511–3524

32.

Ogawa M, Regino CAS, Seidel J, Green MV, Xi W, Williams M, Kosaka N, Choyke PL, Kobayashi H (2009) Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconjug Chem 20(11):2177–2184CrossRef

33.

Li K, Wen S, Larson AC, Shen M, Zhang Z, Chen Q, Shi X, Zhang G (2013) Multifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancer. Int J Nanomedicine 8:2589–2600CrossRef

34.

Chen J, Sun Y, Chen Q, Wang L, Wang S, Tang Y, Shi X, Wang H (2016) Multifunctional gold nanocomposites designed for targeted CT/MR/optical trimodal imaging of human non-small cell lung cancer cells. Nanoscale 8(28):13568–13573CrossRef

35.

Mariani G, Bruselli L, Kuwert T, Kim EE, Flotats A, Israel O, Dondi M, Watanabe N (2010) A review on the clinical uses of SPECT/CT. Eur J Nucl Med Mol Imaging 37(10):1959–1985CrossRef

36.

Thrall MM, DeLoia JA, Gallion H, Avril N (2007) Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol 105(1):17–22CrossRef

37.

Chiti A, Kirienko M, Grégoire V (2010) Clinical use of PET-CT data for radiotherapy planning: what are we looking for? Radiother Oncol 96(3):277–279CrossRef

38.

Delso G, Fürst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, Schwaiger M, Ziegler SI (2011) Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 52(12):1914–1922CrossRef

39.

Drzezga A, Souvatzoglou M, Eiber M, Beer AJ, Fürst S, Martinez-Möller A, Nekolla SG, Ziegler S, Ganter C, Rummeny EJ, Schwaiger M (2012) First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses. J Nucl Med 53(6):845–855CrossRef

40.

Liong M, Lu J, Kovochich M, Xia T, Ruehm SG, Nel AE, Tamanoi F, Zink JI (2008) Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2(5):889–896CrossRef

41.

Rubel C, Hao H, Weibo C (2015) Image-guided drug delivery with single-photon emission computed tomography: a review of literature. Curr Drug Targets 16(6):592–609CrossRef

42.

Guo R, Shi X (2012) Dendrimers in cancer therapeutics and diagnosis. Curr Drug Metab 13(8):1097–1109CrossRef

43.

Chen X, Gambhir SS, Cheon J (2011) Theranostic nanomedicine. Acc Chem Res 44(10):841CrossRef

44.

Namiki Y, Fuchigami T, Tada N, Kawamura R, Matsunuma S, Kitamoto Y, Nakagawa M (2011) Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring. Acc Chem Res 44(10):1080–1093CrossRef

45.

Lusic H, Grinstaff MW (2013) X-ray-computed tomography contrast agents. Chem Rev 113(3):1641–1666CrossRef

46.

Mintzer MA, Grinstaff MW (2011) Biomedical applications of dendrimers: a tutorial. Chem Soc Rev 40(1):173–190CrossRef

47.

Sun W, Mignani S, Shen M, Shi X (2016) Dendrimer-based magnetic iron oxide nanoparticles: their synthesis and biomedical applications. Drug Discov Today 21(12):1873–1885CrossRef

48.

Qiao Z, Shi X (2015) Dendrimer-based molecular imaging contrast agents. Prog Polym Sci 44:1–27CrossRef

49.

Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, Roeck J, Ryder J, Smith P (1985) A new class of polymers: starburst-dendritic macromolecules. Polym J 17(1):117–132CrossRef

50.

Bosman AW, Janssen HM, Meijer EW (1999) About dendrimers: structure, physical properties, and applications. Chem Rev 99(7):1665–1688CrossRef

51.

Tomalia DA, Fréchet JMJ (2002) Discovery of dendrimers and dendritic polymers: a brief historical perspective. J Polym Sci Part A Polym Chem 40(16):2719–2728CrossRef

52.

Shen M, Shi X (2010) Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications. Nanoscale 2(9):1596–1610CrossRef

53.

Tang J, Sheng Y, Hu H, Shen Y (2013) Macromolecular MRI contrast agents: structures, properties and applications. Prog Polym Sci 38(3–4):462–502CrossRef

54.

Kobayashi H, Brechbiel MW (2005) Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 57(15):2271–2286CrossRef

55.

Kobayashi H, Kawamoto S, Jo S-K, Bryant HL, Brechbiel MW, Star RA (2003) Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug Chem 14(2):388–394CrossRef

56.

Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR Jr, Banaszak Holl MM (2007) The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 14(1):107–115CrossRef

57.

Shukla R, Hill E, Shi X, Kim J, Muniz MC, Sun K, Baker JR (2008) Tumor microvasculature targeting with dendrimer-entrapped gold nanoparticles. Soft Matter 4(11):2160–2163CrossRef

58.

Shi X, Wang S, Sun H, Baker JR (2007) Improved biocompatibility of surface functionalized dendrimer-entrapped gold nanoparticles. Soft Matter 3(1):71–74CrossRef

59.

Cao Y, Liu H, Shi X (2015) Targeted CT imaging of cancer cells using PEGylated low-generation dendrimer-entrapped gold nanoparticles. J Control Release 213:e138–e139CrossRef

60.

Zhou B, Zheng L, Peng C, Li D, Li J, Wen S, Shen M, Zhang G, Shi X (2014) Synthesis and characterization of PEGylated polyethylenimine-entrapped gold nanoparticles for blood pool and tumor CT imaging. ACS Appl Mater Interfaces 6(19):17190–17199CrossRef

61.

Wang H, Zheng L, Peng C, Shen M, Shi X, Zhang G (2013) Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma. Biomaterials 34(2):470–480CrossRef

62.

Talanov VS, Regino CAS, Kobayashi H, Bernardo M, Choyke PL, Brechbiel MW (2006) Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging. Nano Lett 6(7):1459–1463CrossRef

63.

Kim Y, Kim SH, Tanyeri M, Katzenellenbogen JA, Schroeder CM (2013) Dendrimer probes for enhanced photostability and localization in fluorescence imaging. Biophys J 104(7):1566–1575CrossRef

64.

Taratula O, Schumann C, Duong T, Taylor KL, Taratula O (2015) Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy. Nanoscale 7(9):3888–3902CrossRef

65.

Bryant LH Jr, Jordan EK, Bulte JWM, Herynek V, Frank JA (2002) Pharmacokinetics of a high-generation dendrimer–Gd-DOTA. Acad Radiol 9(Suppl 1):S29–S33CrossRef

66.

Wen S, Li K, Cai H, Chen Q, Shen M, Huang Y, Peng C, Hou W, Zhu M, Zhang G, Shi X (2013) Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications. Biomaterials 34(5):1570–1580CrossRef

67.

Nwe K, Bernardo M, Regino CAS, Williams M, Brechbiel MW (2010) Comparison of MRI properties between derivatized DTPA and DOTA gadolinium–dendrimer conjugates. Bioorg Med Chem 18(16):5925–5931CrossRef

68.

Luo Y, Zhao L, Li X, Yang J, Guo L, Zhang G, Shen M, Zhao J, Shi X (2016) The design of a multifunctional dendrimer-based nanoplatform for targeted dual mode SPECT/MR imaging of tumors. J Mater Chem B 4(45):7220–7225CrossRef

69.

Li X, Xiong Z, Xu X, Luo Y, Peng C, Shen M, Shi X (2016) 99mTc-labeled multifunctional low-generation dendrimer-entrapped gold nanoparticles for targeted SPECT/CT dual-mode imaging of tumors. ACS Appl Mater Interfaces 8(31):19883–19891CrossRef

70.

Zhao L, Zhu J, Cheng Y, Xiong Z, Tang Y, Guo L, Shi X, Zhao J (2015) Chlorotoxin-conjugated multifunctional dendrimers labeled with radionuclide 131I for single photon emission computed tomography imaging and radiotherapy of gliomas. ACS Appl Mater Interfaces 7(35):19798–19808CrossRef

71.

Seo JW, Baek H, Mahakian LM, Kusunose J, Hamzah J, Ruoslahti E, Ferrara KW (2014) 64Cu-labeled lyp-1-dendrimer for PET-CT imaging of atherosclerotic plaque. Bioconjug Chem 25(2):231–239CrossRef

72.

Ghai A, Singh B, Panwar Hazari P, Schultz MK, Parmar A, Kumar P, Sharma S, Dhawan D, Kumar Mishra A (2015) Radiolabeling optimization and characterization of 68Ga labeled DOTA–polyamido-amine dendrimer conjugate – animal biodistribution and PET imaging results. Appl Radiat Isot 105:40–46CrossRef

73.

Bulte JWM, Douglas T, Witwer B, Zhang S-C, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19(12):1141–1147CrossRef

74.

Strable E, Bulte JWM, Moskowitz B, Vivekanandan K, Allen M, Douglas T (2001) Synthesis and characterization of soluble iron oxide–dendrimer composites. Chem Mater 13(6):2201–2209CrossRef

75.

Shi X, Thomas TP, Myc LA, Kotlyar A, Baker JJR (2007) Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys Chem Chem Phys 9(42):5712–5720CrossRef

76.

Zhou B, Xiong Z, Zhu J, Shen M, Tang G, Peng C, Shi X (2016) PEGylated polyethylenimine-entrapped gold nanoparticles loaded with gadolinium for dual-mode CT/MR imaging applications. Nanomedicine 11(13):1639–1652CrossRef

77.

Chen Q, Wang H, Liu H, Wen S, Peng C, Shen M, Zhang G, Shi X (2015) Multifunctional dendrimer-entrapped gold nanoparticles modified with RGD peptide for targeted computed tomography/magnetic resonance dual-modal imaging of tumors. Anal Chem 87(7):3949–3956CrossRef

78.

Shaw LJ, Iskandrian AE (2004) Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 11(2):171–185CrossRef

79.

Gnanasegaran G, Ballinger JR (2014) Molecular imaging agents for SPECT (and SPECT/CT). Eur J Nucl Med Mol Imaging 41(1):26–35CrossRef

80.

Cutler CS, Hennkens HM, Sisay N, Huclier-Markai S, Jurisson SS (2013) Radiometals for combined imaging and therapy. Chem Rev 113(2):858–883CrossRef

81.

Madsen MT (2007) Recent advances in SPECT imaging. J Nucl Med 48(4):661–673CrossRef

82.

Eckelman WC (2009) Unparalleled contribution of technetium-99m to medicine over 5 decades. J Am Coll Cardiol Img 2(3):364–368CrossRef

83.

Khalil MM, Tremoleda JL, Bayomy TB, Gsell W (2011) Molecular SPECT imaging: an overview. Int J Mol Imaging 2011:796025CrossRef

84.

Niendorf HP, Dinger JC, Haustein J, Cornelius I, Alhassan A, Clauß W (1991) Tolerance data of Gd-DTPA: a review. Eur J Radiol 13(1):15–20CrossRef

85.

Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Am J Roentgenol 142(3):619–624CrossRef

86.

Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15(4):621–628CrossRef

87.

Lorberboym M, Lampl Y, Sadeh M (2003) Correlation of 99mTc-DTPA SPECT of the blood–brain barrier with neurologic outcome after acute stroke. J Nucl Med 44(12):1898–1904

88.

McLarty K, Cornelissen B, Cai Z, Scollard DA, Costantini DL, Done SJ, Reilly RM (2009) Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated her2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts. J Nucl Med 50(8):1340–1348CrossRef

89.

Bar-Shalom R, Yefremov N, Guralnik L, Keidar Z, Engel A, Nitecki S, Israel O (2006) SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med 47(4):587–594

90.

Zhang Y, Sun Y, Xu X, Zhu H, Huang L, Zhang X, Qi Y, Shen Y-M (2010) Radiosynthesis and micro-SPECT imaging of 99mTc-dendrimer poly(amido)-amine folic acid conjugate. Bioorg Med Chem Lett 20(3):927–931CrossRef

91.

Zhang Y, Sun Y, Xu X, Zhang X, Zhu H, Huang L, Qi Y, Shen Y-M (2010) Synthesis, biodistribution, and microsingle photon emission computed tomography (SPECT) imaging study of technetium-99m labeled pegylated dendrimer poly(amidoamine) (PAMAM)−folic acid conjugates. J Med Chem 53(8):3262–3272CrossRef

92.

Xu X, Zhang Y, Wang X, Guo X, Zhang X, Qi Y, Shen Y-M (2011) Radiosynthesis, biodistribution and micro-SPECT imaging study of dendrimer–avidin conjugate. Bioorg Med Chem 19(5):1643–1648CrossRef

93.

Mirzaii M, Seyyedi S, Sadeghi M, Gholamzadeh Z (2010) Cadmium electrodeposition on copper substrate for cyclotron production of 111In radionuclide. J Radioanal Nucl Chem 284(2):333–339CrossRef

94.

Mamede M, Saga T, Ishimori T, Higashi T, Sato N, Kobayashi H, Brechbiel MW, Konishi J (2004) Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin–dendrimer complex. J Control Release 95(1):133–141CrossRef

95.

Bindslev L, Haack-Sørensen M, Bisgaard K, Kragh L, Mortensen S, Hesse B, Kjær A, Kastrup J (2006) Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: effect on cell proliferation and differentiation. Eur J Nucl Med Mol Imaging 33(10):1171–1177CrossRef

96.

Wong KK, Cahill JM, Frey KA, Avram AM (2010) Incremental value of 111-in pentetreotide SPECT/CT fusion imaging of neuroendocrine tumors. Acad Radiol 17(3):291–297CrossRef

97.

Castaldi P, Rufini V, Treglia G, Bruno I, Perotti G, Stifano G, Barbaro B, Giordano A (2008) Impact of 111In-DTPA-octreotide SPECT/CT fusion images in the management of neuroendocrine tumours. Radiol Med 113(7):1056–1067CrossRef

98.

Kojima C, Niki Y, Ogawa M, Magata Y (2014) Prolonged local retention of subcutaneously injected polymers monitored by noninvasive SPECT imaging. Int J Pharm 476(1–2):164–168CrossRef

99.

Keshtgar MRS, Ell PJ (1999) Sentinel lymph node detection and imaging. Eur J Nucl Med 26(1):57–67CrossRef

100.

Xie Y, Bagby TR, Cohen MS, Forrest ML (2009) Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opin Drug Deliv 6(8):785–792CrossRef

101.

Ryan GM, Kaminskas LM, Porter CJH (2014) Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers. J Control Release 193:241–256CrossRef

102.

Koyama Y, Talanov VS, Bernardo M, Hama Y, Regino CAS, Brechbiel MW, Choyke PL, Kobayashi H (2007) A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice. J Magn Reson Imaging 25(4):866–871CrossRef

103.

Jain R, Dandekar P, Patravale V (2009) Diagnostic nanocarriers for sentinel lymph node imaging. J Control Release 138(2):90–102CrossRef

104.

Sano K, Iwamiya Y, Kurosaki T, Ogawa M, Magata Y, Sasaki H, Ohshima T, Maeda M, Mukai T (2014) Radiolabeled γ-polyglutamic acid complex as a nano-platform for sentinel lymph node imaging. J Control Release 194:310–315CrossRef

105.

Niki Y, Ogawa M, Makiura R, Magata Y, Kojima C (2015) Optimization of dendrimer structure for sentinel lymph node imaging: effects of generation and terminal group. Nanomedicine 11(8):2119–2127CrossRef

106.

Willi AK (2006) X-ray computed tomography. Phys Med Biol 51(13):R29CrossRef

107.

Mattrey RF, Aguirre DA (2003) Advances in contrast media research. Acad Radiol 10(12):1450–1460CrossRef

108.

Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T (2010) Iodinated blood pool contrast media for preclinical X-ray imaging applications – a review. Biomaterials 31(24):6249–6268CrossRef

109.

Liu H, Wang H, Xu Y, Shen M, Zhao J, Zhang G, Shi X (2014) Synthesis of PEGylated low generation dendrimer-entrapped gold nanoparticles for CT imaging applications. Nanoscale 6(9):4521–4526CrossRef

110.

Wang H, Zheng L, Guo R, Peng C, Shen M, Shi X, Zhang G (2012) Dendrimer-entrapped gold nanoparticles as potential CT contrast agents for blood pool imaging. Nanoscale Res Lett 7(1):190CrossRef

111.

Peng C, Qin J, Zhou B, Chen Q, Shen M, Zhu M, Lu X, Shi X (2013) Targeted tumor CT imaging using folic acid-modified PEGylated dendrimer-entrapped gold nanoparticles. Polym Chem 4(16):4412–4424CrossRef

112.

Criscione JM, Dobrucki LW, Zhuang ZW, Papademetris X, Simons M, Sinusas AJ, Fahmy TM (2011) Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging. Bioconjug Chem 22(9):1784–1792CrossRef

113.

Xu C, Tung GA, Sun S (2008) Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem Mater 20(13):4167–4169CrossRef

114.

Shi X, Lee I, Baker JR (2008) Acetylation of dendrimer-entrapped gold and silver nanoparticles. J Mater Chem 18(5):586–593CrossRef

115.

Guo R, Wang H, Peng C, Shen M, Pan M, Cao X, Zhang G, Shi X (2010) X-ray attenuation property of dendrimer-entrapped gold nanoparticles. J Phys Chem C 114(1):50–56CrossRef

116.

Jordan LC, McKinstry RC, Kraut MA, Ball WS, Vendt BA, Casella JF, DeBaun MR, Strouse JJ (2010) Incidental findings on brain magnetic resonance imaging of children with sickle cell disease. Pediatrics 126(1):53CrossRef

117.

Beets-Tan RGH, Beets GL (2004) Rectal cancer: review with emphasis on MR imaging. Radiology 232(2):335–346CrossRef

118.

Raymond KN, Pierre VC (2005) Next generation, high relaxivity gadolinium MRI agents. Bioconjug Chem 16(1):3–8CrossRef

119.

Yang C-T, Chuang K-H (2012) Gd(iii) chelates for MRI contrast agents: from high relaxivity to “smart”, from blood pool to blood-brain barrier permeable. Med Chem Commun 3(5):552–565CrossRef

120.

Cheng C-Y, Ou K-L, Huang W-T, Chen J-K, Chang J-Y, Yang C-H (2013) Gadolinium-based CuInS2/ZnS nanoprobe for dual-modality magnetic resonance/optical imaging. ACS Appl Mater Interfaces 5(10):4389–4400CrossRef

121.

Langereis S, de Lussanet QG, van Genderen MHP, Meijer EW, Beets-Tan RGH, Griffioen AW, van Engelshoven JMA, Backes WH (2006) Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging. NMR Biomed 19(1):133–141CrossRef

122.

Cheng Z, Thorek DLJ, Tsourkas A (2010) Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T1 magnetic resonance imaging contrast agent. Angew Chem Int Ed Engl 49(2):346–350CrossRef

123.

Rahmania H, Mutalib A, Ramli M, Levita J (2015) Synthesis and stability test of radiogadolinium(III)-DOTA-PAMAM G3.0-trastuzumab as SPECT-MRI molecular imaging agent for diagnosis of HER-2 positive breast cancer. J Radiat Res Appl Sci 8(1):91–99CrossRef

124.

Lee WI, Bae Y, Bard AJ (2004) Strong blue photoluminescence and ECL from OH-terminated PAMAM dendrimers in the absence of gold nanoparticles. J Am Chem Soc 126(27):8358–8359CrossRef

125.

Wang D, Imae T (2004) Fluorescence emission from dendrimers and its pH dependence. J Am Chem Soc 126(41):13204–13205CrossRef

126.

Tsuchimochi M, Hayama K, Toyama M, Sasagawa I, Tsubokawa N (2013) Dual-modality imaging with 99mTc and fluorescent indocyanine green using surface-modified silica nanoparticles for biopsy of the sentinel lymph node: an animal study. EJNMMI Res 3(1):33CrossRef

127.

Xie J, Lee S, Chen X (2010) Nanoparticle-based theranostic agents. Adv Drug Deliv Rev 62(11):1064–1079CrossRef

128.

Ma Y, Mou Q, Wang D, Zhu X, Yan D (2016) Dendritic polymers for theranostics. Theranostics 6(7):930–947CrossRef

129.

Zhu J, Zhao L, Cheng Y, Xiong Z, Tang Y, Shen M, Zhao J, Shi X (2015) Radionuclide 131I-labeled multifunctional dendrimers for targeted SPECT imaging and radiotherapy of tumors. Nanoscale 7(43):18169–18178CrossRef

130.

Cheng Y, Zhu J, Zhao L, Xiong Z, Tang Y, Liu C, Guo L, Qiao W, Shi X, Zhao J (2016) 131I-labeled multifunctional dendrimers modified with BmK CT for targeted SPECT imaging and radiotherapy of gliomas. Nanomedicine 11(10):1253–1266CrossRef

131.

Vugmeyster Y, DeFranco D, Szklut P, Wang Q, Xu X (2010) Biodistribution of [125I]-labeled therapeutic proteins: application in protein drug development beyond oncology. J Pharm Sci 99(2):1028–1045CrossRef

132.

Shao X, Zhang H, Rajian JR, Chamberland DL, Sherman PS, Quesada CA, Koch AE, Kotov NA, Wang X (2011) 125I-labeled gold nanorods for targeted imaging of inflammation. ACS Nano 5(11):8967–8973CrossRef

133.

Merkel OM, Mintzer MA, Sitterberg J, Bakowsky U, Simanek EE, Kissel T (2009) Triazine dendrimers as nonviral gene delivery systems: effects of molecular structure on biological activity. Bioconjug Chem 20(9):1799–1806CrossRef

134.

Mintzer MA, Merkel OM, Kissel T, Simanek EE (2009) Polycationic triazine-based dendrimers: effect of peripheral groups on transfection efficiency. New J Chem 33(9):1918–1925CrossRef

135.

Merkel OM, Zheng M, Mintzer MA, Pavan GM, Librizzi D, Maly M, Höffken H, Danani A, Simanek EE, Kissel T (2011) Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems. J Control Release 153(1):23–33CrossRef

136.

Lee C, Lo S-T, Lim J, da Costa VCP, Ramezani S, Öz OK, Pavan GM, Annunziata O, Sun X, Simanek EE (2013) Design, synthesis and biological assessment of a triazine dendrimer with approximately 16 paclitaxel groups and 8 PEG groups. Mol Pharm 10(12):4452–4461CrossRef

137.

Xiao W, Luo J, Jain T, Riggs JW, Tseng HP, Henderson PT, Cherry SR, Rowland D, Lam KS (2012) Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer. Int J Nanomedicine 7(9):1587–1597CrossRef

Titel: Dendrimer-Based Nanoplatforms for SPECT Imaging Applications
verfasst von: Lingzhou Zhao
Xiangyang Shi
Jinhua Zhao
Verlag: Springer Berlin Heidelberg
Buch: Nanotechnology Characterization Tools for Biosensing and Medical Diagnosis
Print ISBN: 978-3-662-56332-8

Electronic ISBN: 978-3-662-56333-5

Copyright-Jahr: 2018
DOI: https://doi.org/10.1007/978-3-662-56333-5_12

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht